NLRP3 and atrial fibrillation: Inhibitors of XO or NADPH-oxidase, free-radical scavengers, UATs, and NLRP3 inflammasomes may be used as a means of controlling serum UA levels and lowering the risk of hyperuricemia-induced AF [52].